Mirna Expression in Covid-19

Mirna Expression in Covid-19 Publisher

Roustai Geraylow K¹ ; Hemmati R¹ ; Kadkhoda S² ; Ghafourifard S³

Show Affiliations

1. Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran
2. Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Gene Reports Published:2022

Abstract

Coronavirus disease 2019 (COVID-19) is regarded as a challenge in health system. Several studies have assessed the immune-related aspect of this disorder to identify the host-related factors that affect the course of COVID-19. microRNAs (miRNAs) as potent regulators of immune responses have gained much attention in this regard. Recent studies have shown aberrant expression of miRNAs in COVID-19 in association with disease course. Differentially expressed miRNAs have been enriched in pathways related with inflammation and antiviral immune response. miRNAs have also been regarded as potential therapeutic targets in COVID-19, particularly for management of pathological consequences of COVID-19. In the current review, we summarize the data about dysregulation of miRNAs in COVID-19. © 2022

Related Docs

View other Related Docs

1. The Role of Viral and Host Mirnas in the Control, Progression and Possible Treatment of Covid-19 Disease, Journal of Payavard Salamat (2022)

2. Dysregulated Mirnas Network in the Critical Covid-19: An Important Clue for Uncontrolled Immunothrombosis/Thromboinflammation, International Immunopharmacology (2022)

3. Evaluation of Microrna Expression Pattern (Mir-28, Mir-181A, Mir-34A, and Mir-31) in Patients With Covid-19 Admitted to Icu and Diabetic Covid-19 Patients, Intervirology (2023)

4. The Role of Mirnas in Covid-19 Disease, Future Virology (2021)

5. Analyzing the Expression Pattern of the Noncoding Rnas (Hotair, Pvt-1, Xist, H19, and Mirna-34A) in Pbmc Samples of Patients With Covid-19, According to the Disease Severity in Iran During 2022–2023: A Cross-Sectional Study, Health Science Reports (2024)

6. Evaluation of Mir-200C-3P and Mir-421-5P Levels During Immune Responses in the Admitted and Recovered Covid-19 Subjects, Infection# Genetics and Evolution (2022)

7. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)

8. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

Experts (# of related papers)

View all Related Experts

Reza Afrisham (1)

Ziba Majidi (1)

Style	Citing Format
MLA	Roustai Geraylow K, et al.. "Mirna Expression in Covid-19." Gene Reports, vol. 28, no. , 2022, pp. -.
APA	Roustai Geraylow K, Hemmati R, Kadkhoda S, Ghafourifard S (2022). Mirna Expression in Covid-19. Gene Reports, 28(), -.
Chicago	Roustai Geraylow K, Hemmati R, Kadkhoda S, Ghafourifard S. "Mirna Expression in Covid-19." Gene Reports 28, no. (2022): -.
Harvard	Roustai Geraylow K et al. (2022) 'Mirna Expression in Covid-19', Gene Reports, 28(), pp. -.
Vancouver	Roustai Geraylow K, Hemmati R, Kadkhoda S, Ghafourifard S. Mirna Expression in Covid-19. Gene Reports. 2022;28():-.
BibTex	@article{ author = {Roustai Geraylow K and Hemmati R and Kadkhoda S and Ghafourifard S}, title = {Mirna Expression in Covid-19}, journal = {Gene Reports}, volume = {28}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Roustai Geraylow K AU - Hemmati R AU - Kadkhoda S AU - Ghafourifard S TI - Mirna Expression in Covid-19 JO - Gene Reports VL - 28 IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract